Stock futures pointed sharply higher and gold neared its all-time record to begin the last full trading week of the year.
From top picks ready to make the leap to hidden gems ready for a bigger chance, here's each NHL team's fastest-rising ...
In the first half of 2025, Oracle spent a mind-numbing $20.54 billion on capital expenditures (capex) -- leaving Oracle with ...
Tariffs haven’t tanked the economy. In fact, GDP in the second quarter reached its strongest quarterly growth in nearly two ...
U.S. stock and bond markets caught a break on Monday after another unnerving AI-related shakeout late last week, with ...
Founded in 1990 by three M.I.T. researchers, iRobot introduced its vacuum in 2002. Its restructuring will turn the company ...
There’s no such thing as a sure thing in markets, but some things come pretty close. One of them is the proposition that ...
Likewise, World Liberty Financial, a firm Trump and Steve Witkoff co-founded last year along with their sons, started trading a new token in September. It rose to 25 cents in late September but has ...
California faces an $18 billion deficit by 2026-27 as Democrat Gov. Newsom's spending policies create a structural budget ...
With the transfer portal opening Jan. 2 and the 2026 NFL Draft looming, Penn State can expect plenty of roster turnover. Four players have already opted out of the Pinstripe Bowl and one, cornerback ...
Wall Street's favorite "Magnificent Seven" stock for 2026 has already been a big winner in 2025. No one has Nostradamus-like ...
Argenx SE shares fell the most in seven months after the biotech firm said it will discontinue late-stage trials for an experimental medicine to treat an autoimmune disease affecting the eyes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results